Fabian K. Berger
- Infectious Diseases top 10%
- Epidemiology
- Molecular Biology
- Critical Care and Intensive Care Medicine top 10%
- Surgery
- Co-authors
- Barbara C. GärtnerAlexander MellmannSören L. BeckerLutz von MüllerMarkus BischoffNadine A. SchwabHeinrich V. GroesdonkRainer M. Bohle
- Topics
- Clostridium difficile and Clostridium perfringens research (21 papers)Nosocomial Infections in ICU (8 papers)Antimicrobial Resistance in Staphylococcus (8 papers)
- Cited by
- Infectious DiseasesCritical Care and Intensive Care MedicineApplied Microbiology and Biotechnology
- Journals
- Journal of Medicinal ChemistryFrontiers in MicrobiologyThe American Journal of Gastroenterology
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Fabian K. Berger
28 papers receiving 318 citations
Peers
Comparison fields: 5 of 64
- Infectious Diseases 212
- Epidemiology 115
- Molecular Biology 89
- Critical Care and Intensive Care Medicine 54
- Surgery 43
Countries citing papers authored by Fabian K. Berger
This map shows the geographic impact of Fabian K. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabian K. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabian K. Berger more than expected).
Fields of papers citing papers by Fabian K. Berger
This network shows the impact of papers produced by Fabian K. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabian K. Berger. The network helps show where Fabian K. Berger may publish in the future.
Co-authorship network of co-authors of Fabian K. Berger
This figure shows the co-authorship network connecting the top 25 collaborators of Fabian K. Berger. A scholar is included among the top collaborators of Fabian K. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabian K. Berger. Fabian K. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 12 | |
| 6 | 9 | |
| 7 | 5 | |
| 8 | 9 | |
| 9 | 1 | |
| 10 | 20 | |
| 11 | 13 | |
| 12 | 4 | |
| 13 | 4 | |
| 14 | 9 | |
| 15 | 14 | |
| 16 | 10 | |
| 17 | 12 | |
| 18 | Advantages and disadvantages of rifampicin use in orthopedic patients to avoid Clostridium difficile infections | 4 |
| 19 | 10 | |
| 20 | 2 |
About Fabian K. Berger
Fabian K. Berger is a scholar working on Critical Care and Intensive Care Medicine, Infectious Diseases and Clinical Biochemistry, having authored 32 papers that have together received 325 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (21 papers), Nosocomial Infections in ICU (8 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). The work is most often cited by research in Infectious Diseases (212 citations), Critical Care and Intensive Care Medicine (54 citations) and Applied Microbiology and Biotechnology (19 citations). Fabian K. Berger has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Barbara C. Gärtner, Alexander Mellmann, Sören L. Becker, Lutz von Müller, Markus Bischoff, Nadine A. Schwab, Heinrich V. Groesdonk, Rainer M. Bohle, Matthias Glanemann and Irem Karliova. Their work appears in journals such as Journal of Medicinal Chemistry, Frontiers in Microbiology and The American Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.